ArticleMolecular cancer therapeutics2019

Neuregulin Signaling Is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma.

Marta Baro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.